Results 61 to 70 of about 487,201 (201)

Unbalanced rearrangement der(9;18)(p10;q10) in a patient with polycythemia vera [PDF]

open access: yes, 2011
Case report of a translocation : Unbalanced rearrangement der(9;18)(p10;q10) in a patient with polycythemia ...
Raca, G   +15 more
core   +1 more source

Comparison of different criteria for the diagnosis of primary myelofibrosis reveals limited clinical utility for measurement of serum lactate dehydrogenase

open access: yesHaematologica, 2010
Primary myelofibrosis shows histological and pathogenetic overlap with essential thrombocythemia and polycythemia vera. Several diagnostic classifications have been proposed for primary myelofibrosis, although little is known about their clinical utility.
Philip A. Beer   +2 more
doaj   +1 more source

Burning feet in polycythemia vera – peripheral sensorimotor axonal neuropathy with erythromelalgia

open access: yes, 2015
Uwe Wollina Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany Abstract: Polycythemia vera is a rare myeloproliferative disease. Cutaneous symptoms are uncommon.
Wollina U
core  

No Impact of the Increased Number of Cardiovascular Risk Factors on Thrombosis and Survival in Polycythemia Vera

open access: yes, 2021
Evaluating the impact of cardiovascular (CV) risk factors on overall survival (OS) in polycythemia vera (PV)
Gverić-Krečak, Velka   +6 more
core   +1 more source

Myelopathy due to Spinal Extramedullary Hematopoiesis in a Patient with Polycythemia Vera

open access: yesCase Reports in Orthopedics, 2017
Extramedullary hematopoiesis (EMH) occasionally occurs in patients exhibiting hematological disorders with decreased hematopoietic efficacy. EMH is rarely observed in the spinal epidural space and patients are usually asymptomatic.
Shuhei Ito   +10 more
doaj   +1 more source

Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3

open access: yesHaematologica, 2011
We tested the hypothesis that levels of pentraxin high sensitivity C-reactive protein and pentraxin 3 might be correlated with cardiovascular complications in patients with essential thrombocythemia and polycythemia vera.
Tiziano Barbui   +15 more
doaj   +1 more source

Prevention of thrombosis in polycythemia vera and essential thrombocythemia

open access: yes, 2008
Identifying the most safe and effective strategy for reducing the vascular risk of subjects with polycythemia vera and essential thrombocythemia has always been challenging.
Landolfi, Raffaele, Di Gennaro, Leonardo
core   +1 more source

Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis

open access: yesHaematologica, 2019
Here we critically evaluate the role of elevated hematocrit as the principal determinant of thrombotic risk in polycythemia and erythrocytosis, defined by an expansion of red cell mass.
Victor R. Gordeuk   +2 more
doaj   +1 more source

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

open access: yes, 2020
Interferon-␣ (IFN-␣) is a nonleukemogenic treatment of polycythemia vera ...
Bruno Cassinat   +9 more
core  

Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera

open access: yesHaematologica, 2017
Up to 20% of patients with polycythemia vera have karyotypic abnormalities at the time of the initial diagnosis. However, the cytogenetic abnormalities in polycythemia vera have not been well characterized and their prognostic impact is largely unknown ...
Guilin Tang   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy